Medtronic Xomed, Inc.

Medtronic, Inc.

Xomed-treace Inc.

Xomed Surgical Products, Inc.

Xomed, Inc.

Medtronics Xomed, Inc.

James B Hissong

Avram Scheiner

Matthew Franco Myntti

Dana A Oliver

Mark T Stewart

David E Francischelli

James R Skarda

James R Keogh

David C Hacker

William Charles Brunnett

Kevin Lee McFarlin

Wenjeng Li

Robert K Vaccaro

Dwayne S Yamasaki

John Murdock Murphy

Jennifer Gates Medina

Carla A Pagotto

Maria Charles Vijay Stanislaus

Tino Schuler

Randal C Schulhauser

Cecil O Lewis

Fred B Dinger

Rebecca J Haag

Hotaik Lee

Nadine B Smith

Dennis J Reisdorf

Nathan Andrew Torgerson

Jon P Davis

Roy L Testerman

Robyn Lee Jagler

Robert T Sandgren

Janis Saunier

James L Netterville

Leonid Michael Litvak

Richard T Stone

F Barry Bays

Erik R Scott

Adam J Rivard

Phillip C Falkner

Thomas I Miller

Sean Patrick Skubitz

Kanthaiah Koka

Jeffrey P Bodner

Kristin N Hageman

John E Studer

David J Miller

Erik J Peterson

Edze Jan Tijsma

Christy Leslie Ludlow

Brian J Vaccaro

Walton W Baxter

James J Smith

James R Keough

Maria Nieves Gonzalez Lopez

Pamela Reed Kearney

Ryan B Sefkow

Christopher S Kellar

Kyle A Godwin

Edze J Tijsma

Maria N Gonzalez

Maria Nieves Gonzales Lopez

A medical system for obstructive sleep apnea (OSA) treatment includes therapy delivery circuitry configured to output one or more electrical stimulation signals to a tongue of a patient; sensing circuitry configured to sense one or more compound muscle action potential (CMAP) signals, wherein the one or more CMAP signals are generated in response to the delivery of the one or more electrical stimulation signals; and processing circuitry configured to: cause the therapy delivery circuitry to output the one or more electrical stimulation signals to the tongue; receive information indicative of the one or more CMAP signals from the sensing circuitry; determine, based on the one or more CMAP signals, one or more therapeutic stimulation parameters for the OSA treatment; and cause the therapy delivery circuitry to deliver therapeutic electrical stimulation signals according to at least the determined one or more therapeutic stimulation parameters.

Stimulation therapy for treating obstructive sleep apnea (OSA) based on compound muscle action potential (CMAP)

An implantable neurostimulator (INS) and method of use, the INS including an electrical lead having formed thereon at least a pair of bi-polar electrodes, wherein the electrical lead is configured for placement of the pair of bi-polar electrodes proximate protrusor muscles of a patient, a pulse generator electrically connected to the electrical lead and configured to deliver electrical energy to the pair of bi-polar electrodes, the pulse generator having mounted therein a sensor and a control circuit, and the sensor is configured to generate signals representative of an orientation of the pulse generator and communicate the signals to the control circuit and the control circuit is configured to determine the orientation of the pulse generator and deliver electrical energy to the bi-polar electrodes when the determined orientation correlates to a pre-determined orientation.

Position sensitive lingual muscle stimulation system for obstructive sleep apnea

A system operable to allowing viewing of a physical subject with information regarding at least an item separate from the subject overlaid thereon. The system includes a viewscreen. The system is further able to determine the position of the item relative to the subject.

System and method for assisting visualization during a procedure

A first medical device for obstructive sleep apnea therapy includes therapy delivery circuitry coupled to a first set of electrodes implantable proximate to a first hypoglossal nerve within a tongue of the patient and configured to deliver a first electrical stimulation signal to the first hypoglossal nerve that causes the tongue of the patient to advance and includes information to communicate to a second medical device implantable within the head or neck of the patient and coupled to a second set of electrodes implantable proximate to a second hypoglossal nerve within the tongue of the patient; and sensing circuitry coupled to the first set of electrodes and configured to receive a second electrical stimulation signal, delivered to the second hypoglossal nerve by the second medical device, that includes information that the second medical device communicates to the first medical device.

Multi-device obstructive sleep apnea (OSA) treatment

A system for treatment of obstructive sleep apnea (OSA) is described. The system includes an introducer needle having an elongated body. The introducer needle is configured to create an opening in a tongue of a patient for implantation of a lead for treating OSA. One or more electrically conductive areas are located on the elongated body. A medical device is configured to deliver a stimulation signal via the introducer needle through the one or more electrically conductive areas to the tongue of the patient to stimulate one or more motor points of a protrusor muscle within the tongue of the patient.

Treatment of obstructive sleep apnea (OSA)

Disclosed is a system for stimulation of a subject. The stimulation may be to provide therapy to treat the subject. Stimulation may be of selected muscle groups and/or portions.

System and method for therapy

Position sensitive lingual muscle simulation system for obstructive sleep apnea

An apparatus for monitoring EMG signals of a patient's laryngeal muscles includes an endotracheal tube having an exterior surface. Conductive electrodes are formed on the endotracheal tube. The conductive electrodes are configured to receive the EMG signals from the laryngeal muscles when the endotracheal tube is placed in a trachea of the patient. At least wireless sensor is formed on the endotracheal tube, and is configured to wirelessly transmit information to a processing apparatus.

Endotracheal tube apparatus

A device and method for ablating tissue is disclosed comprising the steps of acquiring an anatomical image of a patient, correlating the image to the patient, guiding an ablating member within the patient while tracking the position of the ablating member in the patient, positioning the ablating member in a desired position to ablate tissue, emitting ablating energy from the ablating member to form an ablated tissue area and removing the ablating member from the patient.

Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions

Tissue and other body structures may be protected using a dry, free-flowing, sterilized mixture of chitosan particles and oxidized polysaccharide particles in sealed packaging. The mixture may assist in returning an injured, inflamed or surgically repaired surface to a normal state, e.g., through one or more healing mechanisms such as modulation of an inflammatory response, phagocytosis, mucosal remodeling, reciliation or other full or partial restoration of normal function.

Polysaccharide particle mixture

Growing community of inventors

Jacksonville, FL, United States of America

James B Hissong